
zzso is the water soluble zzso of the zzso zzso zzso recently evaluated in Phase I zzso zzso in a weekly times four schedule, zzso patients were treated with a dose range of zzso to zzso zzso per zzso Fifteen of 40 of the courses of four doses were interrupted by zzso which prohibited completion of the zzso zzso an intermittent schedule was evaluated utilizing single doses repeated every zzso zzso Twenty-six patients were treated at doses of 5 to 10 zzso zzso is the dose limiting toxicity of both schedules with zzso being more severe than zzso zzso is predictable and zzso on the intermittent zzso It is more severe in patients with heavy prior zzso zzso responses were seen in four patients, one with a zzso zzso of the zzso zzso and three with zzso of the zzso Phase II studies are planned at a starting dose of zzso zzso every zzso weeks in patients with no prior treatment and 5 zzso in patients with prior zzso 

